JointMedica receive Continuity Support Grant for current Innovate UK funded projects
JointMedica receive Continuity Support Grant for current Innovate UK funded projects
JointMedica are set to benefit from a Continuity Support package, providing businesses with help to support projects which have been delayed and affected by the COVID-19 pandemic.
Monies were made available in continuity grants to SMEs and third sector organisations who are existing Innovate UK award holders to ensure the success and delivery of new innovation during the COVID-19 epidemic.
Terence Smith, Managing Director of JointMedica commented;
We are eternally grateful to the innovate UK organisation for their continued support of our development technologies. JointMedica can now continue with our work, striving towards our goals.
For further information visit www.innovateuk.gov.uk
January 31, 2022
Welcome Dr Sharat Kumar Kusuma
JointMedica are delighted to welcome Dr Sharat Kumar Kusuma MD, FAAOS, MBA to our board of Directors.
Sharat brings with him an unrivalled breadth of business and clinical credentials. He currently serves as Chief Medical Officer and Senior Vice President of Strategy and Business Development at Exactech, Inc.
Exactech is a leading global orthopaedic device company and is also a part of the investment portfolio of the marquis private equity firm, Texas Pacific Group (TPG Capital).
In his role as JointMedica Board Director, Sharat will leverage his prior medical, academic, and clinical experience as an orthopaedic surgeon and Associate Chairman of Adult Reconstruction at the OhioHealth Group. Sharat is also an alumnus of the healthcare practice at McKinsey & Company and the healthcare team at Apple, Inc. in Cupertino, California. Sharat's previous high-volume hip and knee arthroplasty practice with a subspecialty focus on hip resurfacing and unicompartmental knee arthroplasty, along with his breadth of high-level business exposure, allow him to excel in his current capacity as the Chief Medical Officer to Exactech.
Sharat readily recognized the Polymotion® Hip resurfacing system's value to the global surgeon and patient community. As a result, he led Exactech's due diligence and subsequent negotiations between Exactech and Terence Smith - Managing Director JointMedica, resulting in an exciting partnership that will re-establish the global hip resurfacing market.
https://www.jointmedica.com/exactech-announces-shareholding-acquisition-of-jointmedica
Dr Sharat Kumar Kusuma MD, FAAOS, MBA
Sharat Kusuma, Prof Derek McMinn, and Andrew McMinn – JointMedica's Directors enjoy dinner in Worcester city centre in January 2022.